Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
about
Roles of IL-33 in Resistance and Tolerance to Systemic Candida albicans InfectionsGalectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitisIL-33 induces nuocytes and modulates liver injury in viral hepatitis.CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation.The Impact of Sterile Inflammation in Acute Liver Injury.Silencing of long noncoding RNA AK139328 attenuates ischemia/reperfusion injury in mouse liversThe alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33Dusp5 negatively regulates IL-33-mediated eosinophil survival and functionThe sterile inflammation in the exacerbation of HBV-associated liver injury.Chinese Herbal Preparation Xuebijing Potently Inhibits Inflammasome Activation in Hepatocytes and Ameliorates Mouse Liver Ischemia-Reperfusion Injury.The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling PathwayIL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected MiceChemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes.TRAF1 is a key mediator for hepatic ischemia/reperfusion injuryImplications for Interleukin-33 in solid organ transplantationHepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphateRole of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma.IL-33 Contributes to Schistosoma japonicum-induced Hepatic Pathology through Induction of M2 MacrophagesThe IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovaniThe role of IL-33 in rheumatic diseasesIL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosisSterile inflammation in hepatic ischemia/reperfusion injury: present concepts and potential therapeutics.Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies.Actual position of interleukin(IL)-33 in atherosclerosis and heart failure: Great Expectations or En attendant Godot?Pivotal roles of ILCs in hepatic diseases.New dog and new tricks: evolving roles for IL-33 in type 2 immunity.Protective role of silent information regulator 1 against hepatic ischemia: effects on oxidative stress injury, inflammatory response, and MAPKs.Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.Oncostatin M induces IL-33 expression in liver endothelial cells in mice and expands ST2+CD4+ lymphocytes.Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B.Phosphorylation of Icariin Can Alleviate the Oxidative Stress Caused by the Duck Hepatitis Virus A through Mitogen-Activated Protein Kinases Signaling Pathways.Nilotinib interferes with the signalling pathways implicated in acetaminophen hepatotoxicity.Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells.Tryptanthrin prevents oxidative stress-mediated apoptosis through AMP-activated protein kinase-dependent p38 mitogen-activated protein kinase activation.Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.IL-33-ST2 Axis in Liver Disease: Progression and Challenge.IL-33 Provides Neuroprotection through Suppressing Apoptotic, Autophagic and NF-κB-Mediated Inflammatory Pathways in a Rat Model of Recurrent Neonatal Seizure.IL-33 exacerbates liver sterile inflammation by amplifying neutrophil extracellular trap formation.Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo.
P2860
Q26747318-40E816BB-6C14-4C82-9009-FCCF018E2226Q28069174-331AFE29-13C7-4346-B263-3DB7423093F8Q28588039-7434FEC2-5DFC-4D39-A538-77307E80D53EQ30385774-0F04A0D3-7700-408C-BEB0-B337A90077A5Q33808159-7C26EDEA-7412-4F44-956E-4DDC31700CE4Q33847610-076B44EF-AE92-486F-8908-25C4311CA093Q35060368-6B04FE8B-19F0-4D8A-BE0C-117703BC7C58Q35106252-130749F1-5B53-43B4-821B-DBCD95405C1FQ35109566-AEC7DFED-CB83-42B3-876E-612A73E07BFBQ35373060-81A75A70-ED48-4B0B-A70A-F0CA255D449EQ35680107-56C5F88A-441E-4D8C-87BF-60E89151D799Q35841956-EEE54EF9-BD48-43B4-9B55-EE0D36B84E5CQ35946057-11A039EE-AA4D-42A1-BDDE-3122FA6436DFQ36110091-F26584BE-F8A5-4381-A958-95C132B02870Q36291138-88644A88-A0A7-4798-A065-EC25FA441CCEQ36807908-1FC1ED4E-51D7-44A5-8C76-2587018E70D1Q36832388-0D723E7A-2292-4B82-ADE3-CB43B779B725Q37001426-B2D22EBA-8D01-4700-91CF-FBD989B4A029Q37116617-48022397-A2F5-461B-A6A2-696BD89B340BQ37174541-A09F9725-D5E6-47D7-906B-86CFAB1261D7Q37208870-BB8CA03F-F5FA-4B37-9CC3-6D182EC0AB8FQ37376114-5BA94892-73E9-461F-B9AC-1D754699BE49Q38065291-940A0891-0F52-49FB-A892-09735D50C025Q38105069-47098B7C-FA65-44DA-972E-353CC4426C58Q38287064-7E977AFA-BCBB-491E-A5CA-9B2101D5AD7EQ38366661-D6B809EE-0696-4F6F-9F17-9A97AF23BC05Q38388349-14C9057C-9667-4219-8DBB-C3157677010CQ38795156-9F63D13B-F903-44EA-861D-7673E74FE831Q39012727-85A94EBA-619F-4471-A378-3B3582B13F5AQ40649385-64E60ED1-6914-438B-8D0D-7D7C058E71BCQ41228712-5402FD77-0A5C-4C2D-BA8F-8DCA3C964D2CQ41919647-083A615C-33AF-4B72-AF99-78797ADF5BCBQ43957073-A1A3B03C-A714-4CE9-855D-184F25DBCAD8Q45863196-8D44475E-4BE6-4076-9206-CFC5916E1F84Q46318138-887AAB81-90AF-4CAB-9DF8-6153D37A4EFEQ46419763-DC9D2F08-07D8-4662-B6B7-FB421C777E3FQ47127784-3557681B-77C4-45B9-91E2-B49C595F6725Q47876979-F1524756-06DA-46E1-BC80-72EF7578875CQ47931356-2116EFE6-7E80-4C44-A06E-883B198D5173Q48096026-3828B957-6D47-4E6E-8B8E-D7C4B9A9BD80
P2860
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
@ast
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
@en
type
label
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
@ast
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
@en
prefLabel
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
@ast
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
@en
P2093
P2860
P356
P1433
P1476
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice
@en
P2093
Alex B Lentsch
Amit D Tevar
Heather L Van Sweringen
John Blanchard
Justin M Burns
Michael J Edwards
Nozomu Sakai
R Cutler Quillin
Rebecca Schuster
P2860
P304
P356
10.1002/HEP.25768
P407
P577
2012-10-01T00:00:00Z